Bloomberg the Company

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Exchange: Copenhagen
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Large Pharma

Novo Nordisk A/S

+ Add to Watchlist


295.500 DKK 4.400 1.47%

As of 11:02:36 ET on 01/30/2015.

Company Profile for Novo Nordisk A/S (NOVOB)

Novo Nordisk A/S develops, produces, and markets pharmaceutical products. The Company focuses on diabetes care and offers insulin delivery systems and other diabetes products. Novo Nordisk also works in areas such as haemostatis management, growth disorders, and hormone replacement therapy. The Company offers educational and training materials. Novo Nordisk markets worldwide.

Contact Information

Novo Nordisk A/S

Novo Alle
Bagsvaerd, 2880
Phone: 45-44-44-88-88
Fax: 45-44-49-05-55

Key Executives for Novo Nordisk A/S (NOVOB)

Lars Rebien SorensenChief Executive OfficerKare SchultzPresident/COO
Jesper BrandgaardExec VP/CFOLars Fruergaard JorgensenExec VP/CIO
Mads Krogsgaard ThomsenExec VP/Chief Science OfficerLise KingoExec VP/Chief of Staffs
Jakob RiisExec VPKasper Roseeuw PoulsenVP/Head:Investor Relations

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

sec ||= nil